Effect of sodium bicarbonate on functional outcome in patients with out-of-hospital cardiac arrest: a post-hoc analysis of a French and North-American dataset.

Pubmed ID: 35297385

Journal: European journal of emergency medicine : official journal of the European Society for Emergency Medicine

Publication Date: June 1, 2022

Affiliation: Université de Paris, INSERM, Paris Cardiovascular Research Centre, Paris, France.

MeSH Terms: Humans, Retrospective Studies, Registries, Cardiopulmonary Resuscitation, Bicarbonates, Emergency Medical Services, Out-of-Hospital Cardiac Arrest, Sodium Bicarbonate

Authors: Touron M, Javaudin F, Lebastard Q, Baert V, Heidet M, Hubert H, Leclere B, Lascarrou JB

Cite As: Touron M, Javaudin F, Lebastard Q, Baert V, Heidet M, Hubert H, Leclere B, Lascarrou JB, RéAC Network. Effect of sodium bicarbonate on functional outcome in patients with out-of-hospital cardiac arrest: a post-hoc analysis of a French and North-American dataset. Eur J Emerg Med 2022 Jun 1;29(3):210-220. Epub 2022 Mar 16.

Studies:

Abstract

BACKGROUND AND IMPORTANCE: No large randomised controlled trial has assessed the potential benefits on neurologic outcomes of prehospital sodium bicarbonate administration in patients with nontraumatic out-of-hospital cardiac arrest (OHCA). OBJECTIVE: To obtain information of assistance in designing a randomised controlled trial of bicarbonate therapy after OHCA in specific patient subgroups. DESIGN: We conducted two, separate, simultaneous, retrospective studies of two distinct, unlinked datasets. SETTING AND PARTICIPANTS: One dataset was a French nationwide population-based registry (RéAC Registry, French dataset) and the other was a randomised controlled trial comparing continuous to interrupted chest compressions in North America (ROC-CCC trial, North-American dataset). INTERVENTION: We investigated whether prehospital bicarbonate administration was associated with better neurologic outcomes. OUTCOME MEASURES AND ANALYSES: The main outcome measure was the functional outcome at hospital discharge. To adjust for potential confounders, we conducted a nested propensity-score-matched analysis with inverse probability-of-treatment weighting. MAIN RESULTS: In the French dataset, of the 54 807 patients, 1234 (2.2%) received sodium bicarbonate and 450 were matched. After propensity-score matching, sodium bicarbonate was not associated with a higher likelihood of favourable functional outcomes on day 30 [adjusted odds ratio (aOR), 0.912; 95% confidence interval (95%CI), 0.501-1.655]. In the North-American dataset, of the 23 711 included patients, 4902 (20.6%) received sodium bicarbonate and 1238 were matched. After propensity-score matching, sodium bicarbonate was associated with a lower likelihood of favourable functional outcomes at hospital discharge (aOR, 0.45; 95% CI, 0.34-0.58). CONCLUSION: In patients with OHCA, prehospital sodium bicarbonate administration was not associated with neurologic outcomes in a French dataset and was associated with worse neurologic outcomes in a North-American dataset. Given the considerable variability in sodium bicarbonate use by different prehospital care systems and the potential resuscitation-time bias in the present study, a large randomised clinical trial targeting specific patient subgroups may be needed to determine whether sodium bicarbonate has a role in the prehospital management of prolonged OHCA.